Answers are grounded in this paper and cite their sources.
Neutrophil to lymphocyte ratio represents a novel prognostic marker which is usually associated with the presence of proinflammatory conditions such as obesity, metabolic syndrome or certain benign and even malignant diseases. Moreover, in cases in which a malignant condition is present, the value of the neutrophil to lymphocyte ratio also seems to be positively corelated with the biological aggressivity of the tumor. The aim of the current paper is to discuss about the most relevant studies which discuss about the role of this parameter as a new biological marker in ovarian cancer patients.
No takes yet. Share an insight, caveat, or question.
Bălescu et al. (2023) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: